Navigation Links
Consumer Product Safety Commission not ready for nanotech
Date:8/21/2008

hthalates have been the subject of thousands of scientific studies documenting their effect on the health of animals and humanssome demonstrating a link between the chemicals and decreased sperm count and sexual malformation in boyswhile little is known about possible chronic hazards associated with nanomaterials. Second, nanomaterials are scientifically far more diverse than phthalates, increasing the complexity involved in understanding their toxicology.

"It took decades of research before lawmakers found the political will to keep lead and phthalates out of toys. It could take a very long time to research and ensure that potentially dangerous nanomaterials are kept out, too," says Rejeski.

The new PEN report includes a number of recommendations Felcher believes will help the CPSC to improve its oversight of nanomaterials in consumer products, including:

  • Building the CPSC's nanotechnology knowledge base and expertise.

  • Identifying companies and industries that are currently manufacturing nanoproducts and request that they submit research studies, risk assessment data and any information they possess that will enable the CPSC scientists to assess nanoproduct safety.

  • Urging Congress to amend the Consumer Product Safety Act to give the CPSC the authority to require manufacturers to identify any nanomaterials in their products.

  • Encouraging Congress to adopt a section Consumer Product Safety Act bill recommended by the National Commission on Product Safety in its 1970 Final Report, which would give the CPSC the authority to promulgate safety standards for "new" consumer products based on new and emerging technologies, including nanotechnology.


'/>"/>

Contact: Julia Moore
julia.moore@wilsoncenter.org
202-691-4025
Project on Emerging Nanotechnologies
Source:Eurekalert

0

GOOD

Page: 1 2 3

Related biology technology :

1. Consumer Advocates Praise Interstate Stem Cell Open Meeting Decision
2. Statement on Direct-To-Consumer Genetic Testing
3. Project on Emerging Nanotechnologies and Consumers Union collaborate on ConsumersTalkNano
4. Consumers Call On Interstate Stem Cell Group To Endorse Open Meetings
5. GlaxoSmithKline Consumer Healthcare Recommends Maintaining FDAS Current Two-Class Drug System
6. California Stem Cell Board Member Violates Conflict Rules; Should Resign From Committee, Consumer Group Says
7. Neptune Technologies & Bioressources Inc. Secures Access to Nationwide Consumer Mass Market in the United States
8. Genelex Corporation Defends Consumers Right to Obtain DNA Information:
9. Wyeth Consumer Healthcare Supports U.S. Food and Drug Administration Decision for Over-the-Counter Cough and Cold Medications in Children under Two Years of Age
10. Consumer Advocate Testifies in Support of Stem Cell Oversight Legislation
11. AMDL Announces New GOODNAK Consumer Anti-Aging Products for Use in Skin Renewal Treatments
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/15/2009)... -- Reportlinker.com announces that a new market ... ,, The Future of Orphan ... Pipeline Analysis and Reimbursement ,, ... Summary ,, The author has ... Orphan Diseases Therapeutics - Market Forecasts to ...
(Date:12/15/2009)... BRIARCLIFF MANOR, N.Y., Dec. 15 The ... announced that the professional society is continuing to ... is being held in Arlington, VA, April 19-21, ... society is encouraging non-members to join the organization ... event. The submission deadline is 12 AM EST, ...
(Date:12/15/2009)... Office has announced the launch of several innovative new ... services in the current economic climate. The first ... to finance legal services over a period of 6, ... in their start-up companies. The second is aimed ... payment arrangements over 6 to 12 month period at ...
(Date:12/14/2009)... third edition of Infusion Nursing: An ... the Infusion Nurses Society (INS), includes Totect(®), the ... are a group of chemotherapy medications including daunorubicin, ... in the treatment of various types of cancer ... to the INS publication: "In September 2007, the ...
Breaking Biology Technology:Reportlinker Adds The Future of Orphan Diseases Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement 2Reportlinker Adds The Future of Orphan Diseases Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement 3Reportlinker Adds The Future of Orphan Diseases Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement 4Reportlinker Adds The Future of Orphan Diseases Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement 5Reportlinker Adds The Future of Orphan Diseases Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement 6Reportlinker Adds The Future of Orphan Diseases Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement 7Reportlinker Adds The Future of Orphan Diseases Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement 8Reportlinker Adds The Future of Orphan Diseases Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement 9Reportlinker Adds The Future of Orphan Diseases Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement 10Reportlinker Adds The Future of Orphan Diseases Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement 11Reportlinker Adds The Future of Orphan Diseases Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement 12Reportlinker Adds The Future of Orphan Diseases Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement 13Reportlinker Adds The Future of Orphan Diseases Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement 14Reportlinker Adds The Future of Orphan Diseases Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement 15Reportlinker Adds The Future of Orphan Diseases Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement 16Reportlinker Adds The Future of Orphan Diseases Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement 17Reportlinker Adds The Future of Orphan Diseases Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement 18The International Society for Medical Publication Professionals Announces Call for Abstracts for Its 6th Annual Meeting 2The International Society for Medical Publication Professionals Announces Call for Abstracts for Its 6th Annual Meeting 3The Prinz Law Office Launches Innovative New Programs to Aid Cash-Strapped Entrepreneurs and Businesses 2Infusion Nurses Society References Totect(R) (Dexrazoxane For Injection) as the Only Antidote for the Treatment of Anthracycline Extravasation 2Infusion Nurses Society References Totect(R) (Dexrazoxane For Injection) as the Only Antidote for the Treatment of Anthracycline Extravasation 3Infusion Nurses Society References Totect(R) (Dexrazoxane For Injection) as the Only Antidote for the Treatment of Anthracycline Extravasation 4Infusion Nurses Society References Totect(R) (Dexrazoxane For Injection) as the Only Antidote for the Treatment of Anthracycline Extravasation 5
... , , , , , ... , changed the course of modern life science research by ... and understand the crucial role of , nucleic acids in ... , Roche Applied Science recognized early-on the importance of this new technology ...
... , , , , Andrew ... David J. Harvey, University of Oxford, Oxford, UK, , ... Protein Analysis , The data presented here can be acquired ... mass spectrometers. , Introduction ,This application ...
... , , David Barnidge , Leo E. Bonilla , Gargi , ... Neuromics, Inc., Minneapolis, MN , Thermo Finnigan, San Jose, CA , , ... ICAT Analysis , , , , The data presented here ... , , , Overview , , , ...
Other Biology Technology:Advantages of Roche Applied Science amplification products 2Advantages of Roche Applied Science amplification products 3Characterization of Protein Oligosaccharides Using MSn 2Characterization of Protein Oligosaccharides Using MSn 3Characterization of Protein Oligosaccharides Using MSn 4Characterization of Protein Oligosaccharides Using MSn 5Quantification of the Purinergic Receptor P2X3 using ICAT and , Orthogonal 2D LC-MS/MS with an Ion Trap Mass Spectrometer 2Quantification of the Purinergic Receptor P2X3 using ICAT and , Orthogonal 2D LC-MS/MS with an Ion Trap Mass Spectrometer 3Quantification of the Purinergic Receptor P2X3 using ICAT and , Orthogonal 2D LC-MS/MS with an Ion Trap Mass Spectrometer 4Quantification of the Purinergic Receptor P2X3 using ICAT and , Orthogonal 2D LC-MS/MS with an Ion Trap Mass Spectrometer 5Quantification of the Purinergic Receptor P2X3 using ICAT and , Orthogonal 2D LC-MS/MS with an Ion Trap Mass Spectrometer 6Quantification of the Purinergic Receptor P2X3 using ICAT and , Orthogonal 2D LC-MS/MS with an Ion Trap Mass Spectrometer 7
(Date:12/15/2009)... brain diseases such as Alzheimer,s and Parkinson,s, doctors can ... help a patient. , But they come up empty-handed ... patients with ataxia disabling disorders that rob people ... neurologists are trying to change that with the help ... Institute of Neurological Disorders and Stroke to establish a ...
(Date:12/15/2009)... at VIB and Ghent University in Flanders, Belgium have ... shock, the major cause of death in intensive care ... gas in mice with septic shock, researchers Anje Cauwels ... much less damage, while their chances of survival increased ... generally assumed that nitric oxide is responsible for the ...
(Date:12/15/2009)... available in German . , Leipzig: Species ... the future distribution of mammals. This is the finding ... indigenous European mammals. The researchers analysed data on species ... the phylogenetic information of the species. Judging by the ... species, mammals seem to adapt fast to changing climatic ...
Breaking Biology News(10 mins):UF to lead national effort to help patients with rare brain disease 2UF to lead national effort to help patients with rare brain disease 3Septic shock: Nitric oxide beneficial after all 2Species distribution models are of only limited value for predicting future mammal distributions 2Hong Kong International Media Conference 2010 58341 1Hong Kong International Media Conference 2010 58341 2Hong Kong International Media Conference 2010 58341 3Hong Kong International Media Conference 2010 58341 4AutismOne 26amp 3B Autism Canada Present 26quot 3BCHANGING THE COURSE OF AUTISM IN CANADA 2009 26quot 3B University of Toronto 58336 1AutismOne 26amp 3B Autism Canada Present 26quot 3BCHANGING THE COURSE OF AUTISM IN CANADA 2009 26quot 3B University of Toronto 58336 2AutismOne 26amp 3B Autism Canada Present 26quot 3BCHANGING THE COURSE OF AUTISM IN CANADA 2009 26quot 3B University of Toronto 58336 3RCRC Independent Review Board Announces DHHS Research Oversight 58331 1RCRC Independent Review Board Announces DHHS Research Oversight 58331 2
... and Infectious Diseases (NIAID), part of the National ... into a large international HIV/AIDS trial comparing continuous ... levels of CD4+ cells has been stopped. Enrollment ... had twice the risk of disease progression (the ...
... human looks at a number, letter or other shape, ... respond to different components of that shape, almost instantaneously ... image that the individual then "sees" and understands, researchers ... from the university's Zanvyl Krieger Mind/Brain Institute describes the ...
... Development of a fundamentally new "candidate," or potential, vaccine ... 60,000 people annually, is reported in the current issue ... bite of infected female sand flies, visceral leishmaniasis infects ... occurring in India, Bangladesh, Nepal, Sudan and Brazil. , ...
Other Biology News:International HIV/AIDS trial finds continuous antiretroviral therapy superior to episodic therapy 2International HIV/AIDS trial finds continuous antiretroviral therapy superior to episodic therapy 3International HIV/AIDS trial finds continuous antiretroviral therapy superior to episodic therapy 4In the mind's eye: How the brain makes a whole out of parts 2Potential vaccine developed for deadly leishmaniasis disease 2Potential vaccine developed for deadly leishmaniasis disease 3
Each Yeast-GFP clone represents an individual S. cerevisiae strain containing an open reading frame with a C-terminal Aequorea Victoria GFP (S65T) fusion tag....
... forces with the Mickle Laboratory Engineering Company ... This tissue sectioning system has been designed ... experiments and to be especially applicable to ... or from small organs. Its special features ...
Without sodium bicarbonate. Sterile, Cell culture tested...
... The Bioactive peptides are molecules of peptidic ... behaviour or activity which can be developed ... chemical and agro-food applications. In this way ... with superior properties for therapeutic applications. Primm ...
Biology Products: